tablet-yellow

Amisulpride (Barhemsys)

Anesthesia Implications

Clinically reviewed by anesthesia providers · Updated

Classification:
Benzamide, selective dopamine D2/D3 receptor antagonist, antiemetic
Therapeutic Effects:
Antiemetic, postoperative nausea and vomiting (PONV) prophylaxis and treatment
Primary Considerations:

PONV prophylaxis - 5 mg IV single dose at induction; combines well with other antiemetic classes for multimodal prophylaxis. PONV rescue - 10 mg IV for established PONV, effective even in patients...

Continue reading

Read the full drug post with a free account

Free. It opens every drug, surgery and condition in the library.

Already have an account?